Home
RareCyte

RareCyte Market Share Analysis for November 2025

Find the latest publications and the peer reviewed papers using RareCyte platforms and technologies.

Health > Biotechnology and Pharmaceuticals

Domainrarecyte.com

Year Founded2009

Employees51 - 200

Annual Revenue$2M - $5M

RareCyte

RareCyte (including company regionals)

rarecyte.com

See more website traffic and engagement information

RareCyte Revenue up to November 2025 is 2M - 5M

revenue generated by RareCyte top domains

RareCyte top domains revenue over 3 years

Revenue for RareCyte top domains

rarecyte.com2M - 5M

See more with Sales Intelligence

Total visits to RareCyte's top domains

Understand RareCyte market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

rarecyte.com2.5K

See more with Sales Intelligence

Avg. visit duration in RareCyte's top domains

Analyze RareCyte engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

rarecyte.com00:00:14

See more with Sales Intelligence

Avg. pageviews on RareCyte's top domains

See how RareCyte keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

rarecyte.com1.72

See more with Sales Intelligence

RareCyte top competitors by domain

Top similar sites in November 2025, ranked by their affinity

shapetx.comCompany NameShape Therapeutics, Inc.Employees51 - 200HQUnited States, Washington, SeattleAnnual revenue$1M - $2MTotal visits866Health > Biotechnology and Pharmaceuticals

Top technologies used by RareCyte

These are the website technologies, by industry, used by RareCyte top domains

Advertising (5)

Google Adsense

Widget (4)

Twemoji

Audio Video Media (3)

YouTube

Marketing (3)

Google Marketing Platform

More Technologies

10

See all

News & Signals from RareCyte

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNavigate BioPharma Services, Inc partners with RareCyte, Inc..Navigate BioPharma Services, Inc. announces collaboration with RareCyte, Inc. to provide enhanced spatial biology capabilities using the Orion(TM) platform.

NewsCancer Research Limited partners with RareCyte, Inc..The Ludwig Harvard team partnered with a Seattle, WA, startup named RareCyte and drew additionally on support from the Ludwig Tumor Atlas project and a Small Business Innovation Research grant from the National Cancer Institute to develop a new microscope and processes at the heart of the Orion platform.

NewsRareCyte, Inc. received financing of $24M in financing on Sep 9th '21.RareCyte, Inc. ("RareCyte" or "the Company") a Life Sciences company developing and manufacturing proprietary platforms enabling precision biology solutions, announced today the completion of a $24M financing from new and existing investors.